Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.

ABSTRACT: At the end of 2019, in China, clinical signs and symptoms of unknown etiology have been reported in several patients whose sample sequencing revealed pneumonia caused by the SARS-CoV-2 virus. COVID-19 is a disease triggered by this virus, and in 2020, the World Health Organization declared it a pandemic. Since then, efforts have been made to find effective therapeutic agents against this disease. Identifying novel natural antiviral drugs can be an alternative to treatment. For this reason, antimicrobial peptides secreted by anurans' skin have gained attention for showing a promissory antiviral effect. Hence, this review aimed to elucidate how and which peptides secreted by anurans' skin can be considered therapeutic agents to treat or prevent human viral infectious diseases. Through a lite

SUBMITTER: de Amaral M 

PROVIDER: S-EPMC9008983 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature